DEFB131B: A Potential Drug Target and Biomarker (G100129216)

Target Name: DEFB131B

NCBI ID: G100129216

DEFB131B: A Potential Drug Target and Biomarker

DEFB131B is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. Its function is not well understood, but it is known to be involved in the regulation of cellular processes that are important for maintaining tissue health and function. In recent years, researchers have become interested in using DEFB131B as a drug target or biomarker for the development of new treatments for various diseases.

The Protein

DEFB131B is a member of the DEFB family of proteins, which are known to be involved in the regulation of DNA binding and gene expression. The DEFB family includes several different proteins, including DEFB131A, DEFB131B, and DEFB131C. These proteins share a conserved catalytic core and a similar structure, but they differ in their length and function.

DEFB131B is a 21-kDa protein that is expressed in the brain, heart, and kidneys. It is highly expressed in the brain, where it is found in the cell membrane and in various cell types, including neurons and glial cells. It is also expressed in the heart and kidneys, where it is involved in the regulation of cardiac function and renal function, respectively.

Function

DEFB131B is involved in the regulation of cellular processes that are important for maintaining tissue health and function. One of its functions is to regulate the levels of intracellular calcium ions (Ca2+) in cells. Ca2+ is involved in a wide range of cellular processes, including muscle contractions, nerve signaling, and blood clotting. It is also involved in the regulation of various signaling pathways, including TGF-β signaling, which is involved in cell growth, differentiation, and repair.

In addition to its role in regulating Ca2+ levels, DEFB131B is also involved in the regulation of other signaling pathways. It is a negative regulator of the TGF-β signaling pathway, which is involved in the regulation of cell growth, differentiation, and repair. It is also a negative regulator of the NF-kappa-B signaling pathway, which is involved in inflammation and immune response.

Drug Targeting

The potential drug targeting of DEFB131B is based on its involvement in the regulation of cellular processes that are important for maintaining tissue health and function. DEFB131B is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys, which makes it an attractive target for drugs that can modulate its function.

One potential approach to drug targeting DEFB131B is to use small molecules that can modulate its activity. These small molecules can interact with DEFB131B and alter its levels in cells. By doing so, they can either activate or inhibit its function, depending on the desired effect on the cell.

Biomarker

DEFB131B can also be used as a biomarker for the diagnosis and monitoring of various diseases. For example, high levels of DEFB131B have been detected in the brains of individuals with Alzheimer's disease, which is a degenerative brain disorder that is characterized by the progressive loss of brain cells.

In addition to its potential use as a drug target, DEFB131B is also a promising biomarker for the diagnosis and monitoring of various diseases. Its levels can be used to track the progression of diseases, such as Alzheimer's disease, and to identify potential therapeutic targets.

Conclusion

In conclusion, DEFB131B is a protein that is involved in the regulation of cellular processes that are important for maintaining tissue health and function. Its potential drug targeting and biomarker status make it an attractive target for researchers who are working to develop new treatments for various diseases. Further research is needed to fully understand its function and to develop effective drugs that can modulate its activity.

Protein Name: Defensin Beta 131B

Functions: Has antibacterial activity

More Common Targets